Business Wire

The Indy Autonomous Challenge Presented by Bridgestone Returns to Goodwood Festival of Speed in July 2024

11.6.2024 17:00:00 EEST | Business Wire | Press release

Share

Returning to showcase the World’s Fastest Autonomous Racecar, the Indy Autonomous Challenge (IAC), presented by Bridgestone, will take on the hillclimb at the Goodwood Festival of Speed presented by Mastercard from July 11th to July 14th, 2024. This year, the IAC’s AV-24 fully autonomous racecar will be piloted by software from the PoliMOVE-MSU team, with support from the UNIMORE Racing team.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611138772/en/

The world's fastest autonomous racecar with an AI pilot coded by students from PoliMOVE-MSU team races on Goodwood Hill. Credit Indy Autonomous Challenge. (Photo: Business Wire)

The IAC has developed the AV-24, a fully autonomous racecar utilizing a Dallara chassis used in the Indy NXT series, and outfitted with a state-of-the-art robotics platform developed with leading autonomous hardware and software providers. To date, the IAC has organized autonomous racing competitions gathering 10 teams comprised of 18 universities at prestigious venues such as the Indianapolis Motor Speedway, Las Vegas Motor Speedway, Texas Motor Speedway, and Monza F1 Circuit—affectionately known as the Temple of Speed. The 2024 Festival of Speed marks the Indy Autonomous Challenge’s competitive debut in the UK, promising to test the technology in new and challenging ways.

Since its inception in 2021, the Indy Autonomous Challenge and its university teams have set several world records for high-speed ground-based autonomy:

  • Autonomous land speed record of 192.2 mph
  • Highest on-track speed of 180 mph
  • Fastest head-to-head overtake on-track at 177 mph
  • Most miles of autonomous racing accumulated: 9,000 miles.

Last year the Indy Autonomous Challenge was introduced to Goodwood in 2023 as part of Future Lab presented by Randox, illustrating the IAC’s significant role in advancing automotive driving technology through global events. Additionally, the Technical University of Munich used their autonomous racecar to conduct a low-speed scan of the Goodwood hill, crafting a digital twin of the course that will help enable this year’s fully autonomous hillclimb.

Paul Mitchell, Chairman and President of the Indy Autonomous Challenge, expressed enthusiasm about the upcoming event, stating, “We are eager to undertake the unique challenges presented by the Goodwood Hillclimb. Unlike the familiar ovals and F1 road courses, Goodwood’s Hillclimb will challenge the precision of sensor perception, GPS localization, vehicle dynamics, and path planning in new ways, providing a historical backdrop to showcase the future of high-speed autonomous mobility and the innovative university teams behind it.”

The event, part of Goodwood’s FOS TECH program, will highlight the latest in automotive technology and alternative fuels, integrating the Future Lab and STEM programs targeted at young people eager to participate in future robotics. IAC university teams’ capabilities will be showcased as they attempt an autonomous world record on the Goodwood hill. Autonomous racing will not only entertain but also offer insights and learnings towards the future of mobility, demonstrating how AI drivers will revolutionize vehicle safety and efficiency on public roads and within supply chains.

The Duke of Richmond, founder of the Festival of Speed, commented on the festival’s role in showcasing technological innovation: “This year, our new FOS TECH ethos will bring together our future technology and mobility content. Whether exploring Future Lab presented by Randox, Electric Avenue, or enjoying content on the Hill, visitors to the Festival of Speed can experience the work of groundbreaking innovators and their vision for tomorrow’s world.”

Sara Correa, Chief Marketing Officer for Bridgestone in the Americas, Europe, Middle East and Africa (EMEA) added, “What really matters is working together to collaboratively develop and advance the future of mobility. Bridgestone is proud to partner with the IAC and its young engineers to test and improve autonomous technologies through opportunities like the Goodwood Hillclimb. Motorsports are the ultimate challenge, and the learnings we gather here can be applied to the sustainable solutions we develop for society and our customers.”

Participating teams: PoliMOVE-MSU - Comprised of members from Politecnico di Milano (Italy), Michigan State University (Michigan), with the support of UNIMORE Racing - University of Modena and Reggio Emilia (Italy)

The IAC’s appearance at Goodwood Festival of Speed will be the first time that an exhibitor has graduated from Future Lab to the Hillclimb. This year’s event will also feature engaging educational sessions, where attendees can explore future technologies such as autonomous vehicles, drones, robots, augmented and virtual reality, generative AI, sensor fusion, and the Internet of Things. These topics will be the focus of a Q&A session in collaboration with Durham University's solar-powered electric car team, which has also worked with Bridgestone to advance sustainable mobility.

Earlier in June, the IAC conducted a series of training sessions on the Goodwood Hillclimb, performing fully autonomous runs of the hill, reaching speeds greater than 177 kph (110mph). Video and photo footage of the training sessions and racecar livery renders dedicated to media use can be found here.

About the IAC: The Indy Autonomous Challenge (IAC) is a non-profit corporation based in Indianapolis, Indiana (USA) that organizes racing competitions among 10 university-affiliated teams representing 18 universities from around the world. Teams program AI drivers to pilot fully autonomous racecars and compete in a series of history-making events at iconic tracks. Based in Indiana, the IAC is working to establish a hub for performance automation in the state and is harnessing the power of innovative competitions to attract the best and the brightest minds from around the globe to further state-of-the-art technology in the safety and performance of autonomous vehicles. The IAC started as a $1 million prize competition with 31 university teams signing up to compete more than three years ago, representing top engineering and technology programs from 15 U.S. states and 11 countries. Follow the IAC @IndyAChallenge on LinkedIn, Twitter, Instagram, Facebook, and YouTube.

About Bridgestone: Bridgestone is a global leader in tires and rubber building on its expertise to provide solutions for safe and sustainable mobility. Headquartered in Tokyo, the company employs approximately 130,000 people globally and conducts business in more than 150 countries and territories worldwide. Bridgestone offers a diverse product portfolio of premium tires and advanced solutions backed by innovative technologies, improving the way people around the world move, live, work and play.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240611138772/en/

Contacts

Marc Ferlet
marc.ferlet@indyautonomouschallenge.com
USA: +1 317 662 5070
FR: +33 6 79 16 96 26

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Acceleronix, IDEMIA Secure Transactions and Orange Announce Flexible, Single-SKU Manufacturing with Quantum-Safe IFPP4.11.2026 17:44:00 EET | Press release

Orange, one of the world’s leading telecom operators, has joined the global quantum-safe In-Factory Profile Provisioning (IFPP) program, jointly launched by Acceleronix and IDEMIA Secure Transactions at MWC Barcelona in February. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104070181/en/ Acceleronix, IDEMIA Secure Transactions and Orange announce flexible, single-SKU manufacturing with quantum-safe IFPP The program enables device makers to build a single product for every market and connect it to the Orange network before it leaves the factory. Acceleronix and IDEMIA Secure Transactions will demonstrate the solution live at electronica 2026, the international electronics trade fair, at Messe München, Hall C2, Stand 601, from 10 to 13 November. Most connected devices share the same weak spot: provisioning and testing on the production line. In-Factory Profile Provisioning (IFPP) addresses this challenge by enabling conne

U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 16:13:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of disease progression or death compared with standard chemoimmunotherapy. Full results from the MANGROVE study will be presented during the Plenary Scientific Session at the 68th American Society of Hematology (ASH) Annual Meeting on December 13, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103605806/en/ BeOne Medicines' flagship U.S. manufacturing and clinical R&D facility at the P

Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 16:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstracts at the 2026 American Society of Hematology (ASH) Annual Meeting, to beheld December 12 – 15, 2026, in New Orleans. “Our ASH presentations demonstrate meaningful progress across our Hematology portfolio to advance novel treatment approaches for people with serious hematologic conditions,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "We are particularly encouraged by the continued clinical progress of INCA033989 in myelofibrosis (MF) and essential thrombocythemia (ET) and the data for latarcibart in von Willebrand disease (VWD) - data that support our goal of advancing differentiated medicines with the potential to meaningfully improve outcomes for patients." Details on key data presentations at ASH include: Oral Presentations INCA033989 (mutCALR) In JAK-Inhibitor Naive Patients with Myelof

Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 16:00:00 EET | Press release

Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMware and IBM environments, without having to go through a lengthy individual tender process. Through Rimini Support™, organizations gain access to a support alternative enabling them to significantly reduce their historical support costs, improve service quality and support respons

Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 16:00:00 EET | Press release

Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye